The Living Guidelines: UA/NSTEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System Polling Results for CLASS IIb Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIb Guidelines

 * 1) The combination of an ACE inhibitor and an angiotensin receptor blocker may be considered in the long-term management of patients recovering from UA/NSTEMI with persistent symptomatic HF and LVEF <40% despite conventional therapy including an ACE inhibitor or an angiotensin receptor blocker alone. (Level of Evidence: B)

 UA/NSTEMI Guidelines Class IIb Recommendation 1 for Inhibition of the Renin-Angiotensin-Aldosterone System should be: CLASS I CLASS IIa CLASS IIb CLASS III